1. Home
  2. AEMD vs VVOS Comparison

AEMD vs VVOS Comparison

Compare AEMD & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

BUY

Current Price

$5.86

Market Cap

4.3M

Sector

Health Care

ML Signal

BUY

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

BUY

Current Price

$0.14

Market Cap

4.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AEMD
VVOS
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.8M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
AEMD
VVOS
Price
$5.86
$0.14
Analyst Decision
Hold
Buy
Analyst Count
2
3
Target Price
★ $13.25
$2.12
AVG Volume (30 Days)
★ 2.4M
1.6M
Earning Date
11-11-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.76
EPS
N/A
★ N/A
Revenue
N/A
★ $17,443,000.00
Revenue This Year
N/A
$24.92
Revenue Next Year
N/A
$56.44
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.05
52 Week Low
$0.53
$0.13
52 Week High
$35.97
$3.28

Technical Indicators

Market Signals
Indicator
AEMD
VVOS
Relative Strength Index (RSI) 58.98 32.21
Support Level $3.20 $0.13
Resistance Level $6.69 $0.55
Average True Range (ATR) 0.34 0.01
MACD -0.14 0.01
Stochastic Oscillator 0.89 40.19

Price Performance

Historical Comparison
AEMD
VVOS

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: